Anorectal melanoma is an uncommon and aggressive mucosal melanocytic malignancy. Due to its rarity, the pre-operative diagnosis remains diffi cult. The fi rst symptoms are non-specifi c such as anal bleeding, anal mass or pain. Although anorectal melanoma carries a poor prognosis; optimal therapeutics strategies are unclear. Surgical resection remains the mainstay of treatment. The optimal surgical procedure for primary tumours is controversial and can vary from wide local excision or endoscopic mucosal resection (EMR) to an abdomino-perineal resection. A high degree of uncertainly exists regarding the benefi t of radiation therapy or chemotherapy. The treatment of advanced melanoma is evolving rapidly with better understanding of the disease biology and immunology. Considerable effort has been devoted to the identifi cation of molecular determinants of response to target therapies and immunotherapy.

Anorectal mucosal melanoma

Malaguarnera G
Conceptualization
;
Catania Vito E
Membro del Collaboration Group
;
Bertino G
Conceptualization
;
Perrotta R;Drago F
Membro del Collaboration Group
;
Malaguarnera M
Membro del Collaboration Group
;
Latteri S
2018-01-01

Abstract

Anorectal melanoma is an uncommon and aggressive mucosal melanocytic malignancy. Due to its rarity, the pre-operative diagnosis remains diffi cult. The fi rst symptoms are non-specifi c such as anal bleeding, anal mass or pain. Although anorectal melanoma carries a poor prognosis; optimal therapeutics strategies are unclear. Surgical resection remains the mainstay of treatment. The optimal surgical procedure for primary tumours is controversial and can vary from wide local excision or endoscopic mucosal resection (EMR) to an abdomino-perineal resection. A high degree of uncertainly exists regarding the benefi t of radiation therapy or chemotherapy. The treatment of advanced melanoma is evolving rapidly with better understanding of the disease biology and immunology. Considerable effort has been devoted to the identifi cation of molecular determinants of response to target therapies and immunotherapy.
malignant melanoma; mucosal melanoma; anorectal tumours; anorectal melanoma; treatment
File in questo prodotto:
File Dimensione Formato  
Anorectal mucosal melanoma Oncotarget 2018.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 1.76 MB
Formato Adobe PDF
1.76 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/316523
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 34
  • ???jsp.display-item.citation.isi??? ND
social impact